Stocks and Investing Stocks and Investing
Fri, March 23, 2018
Thu, March 22, 2018
Wed, March 21, 2018
Tue, March 20, 2018
Mon, March 19, 2018
Fri, March 16, 2018
Thu, March 15, 2018
Wed, March 14, 2018
Tue, March 13, 2018

Alethia Young Maintained (ALNY) at Buy with Increased Target to $154 on, Mar 13th, 2018


Published on 2024-10-26 03:46:29 - WOPRAI
  Print publication without navigation


Alethia Young of Credit Suisse, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy with Increased Target from $151 to $154 on, Mar 13th, 2018.

Alethia has made no other calls on ALNY in the last 4 months.



There are 3 other peers that have a rating on ALNY. Out of the 3 peers that are also analyzing ALNY, 2 agree with Alethia's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • David Lebovitz of "Morgan Stanley" Maintained at Hold with Decreased Target to $118 on, Friday, February 9th, 2018
  • Paul Matteis of "Leerink Swann" Maintained at Hold with Increased Target to $135 on, Thursday, January 25th, 2018


This is the rating of the analyst that currently disagrees with Alethia


  • Do Kim of "BMO Capital" Maintained at Buy with Decreased Target to $160 on, Friday, February 9th, 2018